ArticleOncotarget2016
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.
Anders E Berglund et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it